Urologix Doubles Presence In BPH Treatment Via $20 Mil. Prostatron Buy

Addition of Edap's Prostatron transurethral microwave thermotherapy (TUMT) system for treatment of benign prostatic hyperplasia (BPH) doubles Urologix' market presence in the BPH treatment area, the firm says. Urologix also expects the total number of cooled microwave thermotherapy procedures performed "to double in the next year" due to expanded market acceptance of the treatment.

More from Archive

More from Medtech Insight